Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Abstract Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to delay viral rebound when administered to people with HIV-1 (PWH) during anti-retroviral therapy (ART) interruption. To further enhance the performance of bNAbs through their Fc effec...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Steven W. de Taeye, Angela I. Schriek, Jeffrey C. Umotoy, Marloes Grobben, Judith A. Burger, Rogier W. Sanders, Gestur Vidarsson, Manfred Wuhrer, David Falck, Neeltje A. Kootstra, Marit J. van Gils
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Nature Portfolio 2024-08-01
Sarja:Communications Biology
Linkit:https://doi.org/10.1038/s42003-024-06659-8

Internet

https://doi.org/10.1038/s42003-024-06659-8

Samankaltaisia teoksia